To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
21st Century Oncology, owned by debt holders, launches auction amid comeback
Almost two years after emerging from Chapter 11 bankruptcy, 21st Century Oncology is evaluating a sale that could ultimately value the newly-led cancer treatment company around $1 billion, according to people familiar with the matter.
